JP2017531425A5 - - Google Patents

Download PDF

Info

Publication number
JP2017531425A5
JP2017531425A5 JP2017516783A JP2017516783A JP2017531425A5 JP 2017531425 A5 JP2017531425 A5 JP 2017531425A5 JP 2017516783 A JP2017516783 A JP 2017516783A JP 2017516783 A JP2017516783 A JP 2017516783A JP 2017531425 A5 JP2017531425 A5 JP 2017531425A5
Authority
JP
Japan
Prior art keywords
stem cells
mesenchymal stem
population
induction medium
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017516783A
Other languages
English (en)
Japanese (ja)
Other versions
JP6890538B2 (ja
JP2017531425A (ja
Filing date
Publication date
Priority claimed from US14/504,399 external-priority patent/US20160095885A1/en
Application filed filed Critical
Publication of JP2017531425A publication Critical patent/JP2017531425A/ja
Publication of JP2017531425A5 publication Critical patent/JP2017531425A5/ja
Priority to JP2021068586A priority Critical patent/JP7672867B2/ja
Application granted granted Critical
Publication of JP6890538B2 publication Critical patent/JP6890538B2/ja
Priority to JP2023077664A priority patent/JP7773502B2/ja
Priority to JP2025091622A priority patent/JP2025131663A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017516783A 2014-10-01 2015-09-24 幹細胞培養および療法のための誘導培地および方法 Active JP6890538B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2021068586A JP7672867B2 (ja) 2014-10-01 2021-04-14 幹細胞培養および療法のための誘導培地および方法
JP2023077664A JP7773502B2 (ja) 2014-10-01 2023-05-10 幹細胞培養および療法のための誘導培地および方法
JP2025091622A JP2025131663A (ja) 2014-10-01 2025-06-02 幹細胞培養および療法のための誘導培地および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/504,399 US20160095885A1 (en) 2014-10-01 2014-10-01 Induction Medium & Methods for Stem Cell Culture & Therapy
US14/504,399 2014-10-01
PCT/US2015/052029 WO2016053758A1 (en) 2014-10-01 2015-09-24 Induction medium and methods for stem cell culture and therapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021068586A Division JP7672867B2 (ja) 2014-10-01 2021-04-14 幹細胞培養および療法のための誘導培地および方法

Publications (3)

Publication Number Publication Date
JP2017531425A JP2017531425A (ja) 2017-10-26
JP2017531425A5 true JP2017531425A5 (enExample) 2018-11-08
JP6890538B2 JP6890538B2 (ja) 2021-06-18

Family

ID=55631287

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2017516783A Active JP6890538B2 (ja) 2014-10-01 2015-09-24 幹細胞培養および療法のための誘導培地および方法
JP2021068586A Active JP7672867B2 (ja) 2014-10-01 2021-04-14 幹細胞培養および療法のための誘導培地および方法
JP2023077664A Active JP7773502B2 (ja) 2014-10-01 2023-05-10 幹細胞培養および療法のための誘導培地および方法
JP2025091622A Pending JP2025131663A (ja) 2014-10-01 2025-06-02 幹細胞培養および療法のための誘導培地および方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021068586A Active JP7672867B2 (ja) 2014-10-01 2021-04-14 幹細胞培養および療法のための誘導培地および方法
JP2023077664A Active JP7773502B2 (ja) 2014-10-01 2023-05-10 幹細胞培養および療法のための誘導培地および方法
JP2025091622A Pending JP2025131663A (ja) 2014-10-01 2025-06-02 幹細胞培養および療法のための誘導培地および方法

Country Status (11)

Country Link
US (6) US20160095885A1 (enExample)
EP (2) EP4234032A3 (enExample)
JP (4) JP6890538B2 (enExample)
KR (10) KR102636786B1 (enExample)
CN (1) CN107002029A (enExample)
AU (4) AU2015324241B2 (enExample)
CA (2) CA3210154A1 (enExample)
ES (1) ES2961691T3 (enExample)
MX (1) MX2017004288A (enExample)
RU (1) RU2717983C2 (enExample)
WO (1) WO2016053758A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160095885A1 (en) 2014-10-01 2016-04-07 WibiWorks Therapeutics, Inc. Induction Medium & Methods for Stem Cell Culture & Therapy
JP7168448B2 (ja) 2015-12-07 2022-11-09 コロラド ステート ユニバーシティー リサーチ ファウンデーション 感染創傷のための活性化幹細胞を含む組成物
CA3019574C (en) * 2016-03-31 2025-09-23 Sanbio Inc Medium, methods, cells and secreted factors for stem cell culture and therapy
WO2018067925A1 (en) * 2016-10-06 2018-04-12 Transgenex Nanobiotech, Inc. Methods for cancer stem cell (csc) expansion
CN110121553A (zh) * 2016-10-27 2019-08-13 纽约哥伦比亚大学董事会 免疫抑制性间充质细胞及其形成方法
JP7237301B2 (ja) * 2016-12-16 2023-03-13 有限会社大阪空気機械サービス 組織治癒剤
JP7363003B2 (ja) * 2018-06-11 2023-10-18 ヘルス、アンド、バイオテック、フランス（アッシュ、アンド、ベー、フランス） 間葉系幹細胞由来細胞外小胞
WO2020045399A1 (ja) * 2018-08-29 2020-03-05 株式会社Ｒｅｇｅｎｅ Ｐｈａｒｍ がんの治療のための医薬組成物
MX2021004924A (es) 2018-10-30 2021-08-16 Vitabolus Inc Administracion oral de celulas terapeuticas de mamiferos.
WO2021007180A1 (en) * 2019-07-05 2021-01-14 Case Western Reserve University Priming media and methods for stem cell culture and therapy
US20230257713A1 (en) * 2020-07-16 2023-08-17 Shanghai Jiaotong University Immunotherapy method of targeted chemokine and cytokine delivery by mesenchymal stem cell
KR102460408B1 (ko) * 2020-07-23 2022-10-28 포항공과대학교 산학협력단 줄기세포 시트를 제조하는 방법
TWI888659B (zh) * 2021-10-13 2025-07-01 芯芮生技開發股份有限公司 幹細胞條件培養基於製備抑制癌症組成物的用途
KR20250076941A (ko) * 2023-11-23 2025-05-30 (주) 넥셀 인간 전분화능 줄기세포 유래 심장 오가노이드를 이용해 허혈-재관류 손상에 의해 성체 급성 심근경색 및 심부전 질환이 유도된 체외 질환 모사 모델 제조 방법 및 이를 통해 제조된 체외 질환 모사 모델

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855510B2 (en) * 2001-03-20 2005-02-15 Dana Farber Cancer Institute, Inc. Pharmaceuticals and methods for treating hypoxia and screening methods therefor
EP2298861B1 (en) 2004-03-22 2017-09-13 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
WO2005113751A1 (en) 2004-05-14 2005-12-01 Becton, Dickinson And Company Cell culture environments for the serum-free expansion of mesenchymal stem cells
WO2007136673A2 (en) 2006-05-19 2007-11-29 Medistem Laboratories, Inc. Treatment of disc degenerative disease and compositions for same
WO2009114860A2 (en) 2008-03-14 2009-09-17 The Board Of Trustees Of The University Of Illinois Activated mesenchymal stem cells for the prevention and repair of inflammatory states
DK2285951T3 (en) 2008-05-28 2018-10-22 Univ Ramot TREATMENT OF CNS DISEASES OF CNS DISEASES
CN101407790B (zh) * 2008-10-30 2010-09-29 浙江大学 一种增强人骨髓间充质干细胞旁分泌能力的处理方法
WO2011068792A2 (en) * 2009-12-01 2011-06-09 The Regents Of The University Of California Compositions and methods for making and using bone marrow mesenchymal stem cells and erythroid progenitor cells
WO2012051210A2 (en) 2010-10-11 2012-04-19 The Administrators Of The Tulane Educational Fund Mesenchymal stem cells and related therapies
US8785190B2 (en) 2011-04-06 2014-07-22 Sanbio, Inc. Methods and compositions for modulating peripheral immune function
WO2012150707A1 (ja) 2011-05-02 2012-11-08 国立大学法人熊本大学 幹細胞からインスリン産生細胞への分化誘導を促進する低分子化合物および該化合物を用いた幹細胞からインスリン産生細胞への分化誘導方法
KR102108245B1 (ko) * 2011-11-30 2020-05-08 아스텔라스 인스티튜트 포 리제너러티브 메디슨 중간엽 간질 세포 및 이에 관련된 용도
EP2872619B1 (en) * 2012-07-11 2018-02-14 Imstem Biotechnology Inc. Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
US20160095885A1 (en) 2014-10-01 2016-04-07 WibiWorks Therapeutics, Inc. Induction Medium & Methods for Stem Cell Culture & Therapy
CN104845933A (zh) * 2015-05-15 2015-08-19 大连理工大学 一种增强脂肪间充质干细胞免疫学性能和迁移能力的方法
CA3019574C (en) 2016-03-31 2025-09-23 Sanbio Inc Medium, methods, cells and secreted factors for stem cell culture and therapy

Similar Documents

Publication Publication Date Title
JP2017531425A5 (enExample)
Ferrari et al. Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
AU2020223733B2 (en) Compositions and methods for the treatment of hemoglobinopathies
Antoniou et al. Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression
AU2013290146B2 (en) Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
CN108064280B (zh) 利用以凝血因子viii基因为靶的核酸内切酶的a型血友病治疗用组合物
Tsuji et al. Secretomes from mesenchymal stem cells against acute kidney injury: possible heterogeneity
JP2021182934A (ja) アルファ１アンチトリプシン欠乏症の治療のための材料および方法
Maeda et al. CXCL12 and osteopontin from bone marrow-derived mesenchymal stromal cells improve muscle regeneration
US20210161967A1 (en) Extracellular vesicles and uses thereof
CN114174493A (zh) 使用带电表面从诱导多能干细胞产生多个谱系的方法
Broxmeyer et al. Fate of hematopoiesis during aging. What do we really know, and what are its implications?
WO2022155458A1 (en) Systems and methods for base editing of hbg1/2 gene promoter and fetal hemoglobin induction
Su et al. Few single nucleotide variations in exomes of human cord blood induced pluripotent stem cells
EP4010361A1 (en) Methods and compositions for reconstituting microglia
Choi et al. Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington’s disease
EP3773637A1 (en) Methods for treating sickle cell disease
US20200354741A1 (en) Gene-editing systems for modifying a scn9a or scn10a gene and methods of use thereof
Fontana et al. Multiplex base editing of BCL11A regulatory elements to treat sickle cell disease
US20240269189A1 (en) Extracellular vesicle-enriched secretome composition derived from induced pluripotent stem cell derived-microglia and methods of use thereof
Arasaratnam et al. The role of cardiac transcription factor NKX2-5 in regulating the human cardiac miRNAome
WO2019111198A1 (en) Extracellular vesicles and uses thereof
US20230392145A1 (en) Promoting nutrient absorption through the colon
Brito Minicircle production and delivery to human mesenchymal stem/stromal cells for angiogenesis stimulation
WO2024015933A2 (en) Transplanting stem cell-derived microglia to treat leukodystrophies